Similar articles

• Medicine. Old drug, new hope for Marfan syndrome.

  Travis J. Travis J. Science. 2006 Apr 7;312(5770):36-7. doi: 10.1126/science.312.5770.36b. Science. 2006. PMID: 16601163 No abstract available.
• Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice.

  Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC. Holm TM, et al. Science. 2011 Apr 15;332(6027):358-61. doi: 10.1126/science.1192149. Science. 2011. PMID: 21493862 Free PMC article.
• ARB may be superior to ACEI on treatment of Marfan's syndrome by blocking TGF-β mediated activation of ERK.

  Yang Y, Cui Y, Peng DQ. Yang Y, et al. Int J Cardiol. 2012 Mar 22;155(3):482-3. doi: 10.1016/j.ijcard.2011.12.070. Epub 2012 Jan 10. Int J Cardiol. 2012. PMID: 22236512 No abstract available.
• The role of transforming growth factor-beta in Marfan syndrome.

  Benke K, Ágg B, Szilveszter B, Tarr F, Nagy ZB, Pólos M, Daróczi L, Merkely B, Szabolcs Z. Benke K, et al. Cardiol J. 2013;20(3):227-34. doi: 10.5603/CJ.2013.0066. Cardiol J. 2013. PMID: 23788295 Review.
• Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys-Dietz Syndromes.

  Takeda N, Yagi H, Hara H, Fujiwara T, Fujita D, Nawata K, Inuzuka R, Taniguchi Y, Harada M, Toko H, Akazawa H, Komuro I. Takeda N, et al. Int Heart J. 2016 May 25;57(3):271-7. doi: 10.1536/ihj.16-094. Epub 2016 May 13. Int Heart J. 2016. PMID: 27181042 Review.